Year: 2005

JSE listed Aspen Pharmacare, Africa’s largest pharmaceutical manufacturer and the leading global player in generic anti-retrovirals (ARVs), earlier today opened a R1 million wellness centre in the Eastern Cape. Through a public-private partnership, Aspen’s investment in the establishment of the Wells Estate Wellness Centre will enhance the primary healthcare services at the Nelson Mandela Bay… Continue reading Aspen Opens R1 million Wellness Centre

JSE listed Aspen Pharmacare Holdings Limited and Lupin Limited of India have entered into an agreement to collaborate in the tuberculosis (TB) related products market in South Africa. The agreement involves cooperation in the areas of technology, manufacture and marketing. Stephen Saad, Aspen Group Chief Executive said, “the agreement enhances South Africa and Aspen’s ability… Continue reading Aspen and Lupin sign TB deal

Aspen Pharmacare Holdings Limited (Aspen) has signed definitive joint venture (JV) agreements with Indian-based Matrix Laboratories Limited (Matrix). The deals strengthen Aspen’s vertical integration into the manufacture of Active Pharmaceutical Ingredients (APIs), the key raw materials required in the manufacture of finished dosage form pharmaceuticals including anti-retrovirals (ARVs), and they unlock additional global supply and… Continue reading Aspen and India’s Matrix sign JVs